Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
4.0
3.8
Journals
Bioengineering
Special Issues
Extracellular Vesicles: From Biology to Biomedical Application
share announcement

Extracellular Vesicles: From Biology to Biomedical Application

A special issue of Bioengineering (ISSN 2306-5354).

Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 19460

Special Issue Editor

Dr. Prakash Gangadaran

E-Mail Website
Guest Editor
Department of Biomedical Science & Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea
Interests: extracellular vesicles; wound healing; regenerative medicine; MSCs
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

Extracellular Vesicles (EVs), which include small EVs or exosomes and microvesicles, are a subtype of membrane vesicles released from the endocytic compartment of live cells. EVs play an important role in local and distant cell-to-cell communication. EVs are able to transport functional biological cargoes (nucleic acids, lipids, proteins, etc.). These aspects of drug delivery are essential for the field of gene therapy. Recent studies have shown that EVs may be used to encapsulate and protect exogenous siRNA/miRNAs or edogeneous miRNA/mRNA for delivery to target cells. Thus, EV-mediated nanodelivery is very promising and may bridge the gap in current delivery systems for systemic gene therapy. 

You may choose our Joint Special Issue in Life.

Dr. Prakash Gangadaran
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • extracellular vesicles
  • exosomes
  • microvesicles exosome mimetics/bionanovesicles
  • miRNA
  • mRNA
  • siRNA
  • gene therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers (4 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

15 pages, 2597 KiB  
Review
Evolution and Clinical Advances of Platelet-Rich Fibrin in Musculoskeletal Regeneration
by Ragunanthan Narayanaswamy, Bishnu Prasad Patro, Naveen Jeyaraman, Prakash Gangadaran, Ramya Lakshmi Rajendran, Arulkumar Nallakumarasamy, Madhan Jeyaraman, Prasanna Ramani and Byeong-Cheol Ahn
Bioengineering 2023, 10(1), 58; https://doi.org/10.3390/bioengineering10010058 - 3 Jan 2023
Cited by 23 | Viewed by 7497
Abstract
Over the past few decades, various forms of platelet concentrates have evolved with significant clinical utility. The newer generation products, including leukocyte-platelet-rich fibrin (L-PRF) and advanced platelet-rich fibrin (A-PRF), have shown superior biological properties in musculoskeletal regeneration than the first-generation concentrates, such as [...] Read more.
Over the past few decades, various forms of platelet concentrates have evolved with significant clinical utility. The newer generation products, including leukocyte-platelet-rich fibrin (L-PRF) and advanced platelet-rich fibrin (A-PRF), have shown superior biological properties in musculoskeletal regeneration than the first-generation concentrates, such as platelet-rich plasma (PRP) and plasma rich in growth factors. These newer platelet concentrates have a complete matrix of physiological fibrin that acts as a scaffold with a three-dimensional (3D) architecture. Further, it facilitates intercellular signaling and migration, thereby promoting angiogenic, chondrogenic, and osteogenic activities. A-PRF with higher leukocyte inclusion possesses antimicrobial activity than the first generations. Due to the presence of enormous amounts of growth factors and anti-inflammatory cytokines that are released, A-PRF has the potential to replicate the various physiological and immunological factors of wound healing. In addition, there are more neutrophils, monocytes, and macrophages, all of which secrete essential chemotactic molecules. As a result, both L-PRF and A-PRF are used in the management of musculoskeletal conditions, such as chondral injuries, tendinopathies, tissue regeneration, and other sports-related injuries. In addition to this, its applications have been expanded to include the fields of reconstructive cosmetic surgery, wound healing in diabetic patients, and maxillofacial surgeries. Full article
(This article belongs to the Special Issue Extracellular Vesicles: From Biology to Biomedical Application)
►▼ Show Figures

Graphical abstract

9 pages, 642 KiB  
Review
Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells
by Daria S. Chulpanova, Tamara V. Pukhalskaia, Albert A. Rizvanov and Valeriya V. Solovyeva
Bioengineering 2022, 9(6), 245; https://doi.org/10.3390/bioengineering9060245 - 4 Jun 2022
Cited by 12 | Viewed by 2671
Abstract
Tumor-cell-derived extracellular vesicles (EVs) are known to carry biologically active molecules of parental cells, which can actively modulate the tumor microenvironment. EVs produced by tumor cells play significant roles in the development and maintenance of tumor growth, metastasis, immune escape, and other important [...] Read more.
Tumor-cell-derived extracellular vesicles (EVs) are known to carry biologically active molecules of parental cells, which can actively modulate the tumor microenvironment. EVs produced by tumor cells play significant roles in the development and maintenance of tumor growth, metastasis, immune escape, and other important processes. However, the ability of EVs to induce the transformation of normal cells has hardly been investigated. This review discusses studies that describe the ability of tumor-cell-derived EVs to alter the metabolism and morphology of normal cells, causing changes associated with malignant transformation. Additionally, the horizontal transfer of oncogenes through EVs of tumor cells and the induction of epigenetic changes in normal cells, which leads to genomic instability and subsequent oncogenic transformation of normal cells, are also discussed. Full article
(This article belongs to the Special Issue Extracellular Vesicles: From Biology to Biomedical Application)
►▼ Show Figures

Figure 1

14 pages, 1431 KiB  
Review
Designer Exosomes: Smart Nano-Communication Tools for Translational Medicine
by Madhyastha Harishkumar, Madhyastha Radha, Nakajima Yuichi, Gothandam Kodiveri Muthukalianan, Ohe Kaoru, Koichiro Shiomori, Kentaro Sakai and Watanabe Nozomi
Bioengineering 2021, 8(11), 158; https://doi.org/10.3390/bioengineering8110158 - 26 Oct 2021
Cited by 16 | Viewed by 3614
Abstract
Exosomes are the master transporters of genes, RNAs, microRNAs, proteins, and lipids. They have applications in major diseases, including cancer, cardiovascular diseases, neurological disorders, and diabetes mellitus. Delivery of the exosomes to recipient cells is governed by the functional heterogenicity of the tissues. [...] Read more.
Exosomes are the master transporters of genes, RNAs, microRNAs, proteins, and lipids. They have applications in major diseases, including cancer, cardiovascular diseases, neurological disorders, and diabetes mellitus. Delivery of the exosomes to recipient cells is governed by the functional heterogenicity of the tissues. Engineered exosomes are promising tools in tissue regeneration. In addition to their role as intracellular communication cargos, exosomes are increasingly primed as standard biomarkers in the progression of diseases, thereby solving the diagnostic dilemma. Futuristic empowerment of exosomes with OMICS strategy can undoubtedly be a bio-tool in translational medicine. This review discusses the advent transformation of exosomes in regenerative medicine and limitations that are caveats to broader applications in clinical use. Full article
(This article belongs to the Special Issue Extracellular Vesicles: From Biology to Biomedical Application)
►▼ Show Figures

Figure 1

31 pages, 1894 KiB  
Review
Bioengineering of Extracellular Vesicles: Exosome-Based Next-Generation Therapeutic Strategy in Cancer
by Priyanka Saha, Suchisnigdha Datta, Sukanya Ghosh, Anurima Samanta, Paramita Ghosh and Dona Sinha
Bioengineering 2021, 8(10), 139; https://doi.org/10.3390/bioengineering8100139 - 10 Oct 2021
Cited by 5 | Viewed by 4689
Abstract
Extracellular nano vesicles and exosomes hold compelling evidence in intercellular communication. Exosomal intracellular signal transduction is mediated by the transfer of cargo proteins, lipids, micro (mi)RNAs, long noncoding (lnc)RNAs, small interfering (si)RNAs, DNA, and other functional molecules that play a pivotal role in [...] Read more.
Extracellular nano vesicles and exosomes hold compelling evidence in intercellular communication. Exosomal intracellular signal transduction is mediated by the transfer of cargo proteins, lipids, micro (mi)RNAs, long noncoding (lnc)RNAs, small interfering (si)RNAs, DNA, and other functional molecules that play a pivotal role in regulating tumor growth and metastasis. However, emerging research trends indicate that exosomes may be used as a promising tool in anticancer treatment. This review features a majority of the bioengineering applications of fabricated exosomal cargoes. It also encompasses how the manipulation and delivery of specific cargoes—noncoding RNAs (ncRNAs), recombinant proteins, immune-modulators, chemotherapeutic drugs, and other small molecules—may serve as a precise therapeutic approach in cancer management. Full article
(This article belongs to the Special Issue Extracellular Vesicles: From Biology to Biomedical Application)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Back to TopTop